Carolyn Magill

Carolyn Magill is CEO of Aetion, Inc, a healthcare technology company delivering real-world evidence for life sciences, payers, providers, and regulatory agencies. She previously served in senior leadership roles at three companies driving the transition from fee-for-service to value-based care: CEO of Remedy Partners; executive vice president of Payer Strategy and Operations at Evolent Health; and in several leadership roles within the Medicare and Medicaid businesses of UnitedHealth Group. Carolyn earned her bachelor’s degree at Harvard University and her MBA in healthcare management from The Wharton School of Business at the University of Pennsylvania.